CME Group FY2027 EPS Forecast Decreased by Erste Group Bank

CME Group Inc. (NASDAQ:CME) – Erste Group Bank lowered their FY2027 EPS estimates for shares of CME Group in a note issued to investors on Monday, July 27th. Erste Group Bank analyst H. Engel now forecasts that the financial services provider will post earnings per share of $12.91 for the year, down from their previous forecast of $12.94. Erste Group Bank has a “Hold” rating on the stock. The consensus estimate for CME Group’s current full-year earnings is $12.27 per share.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter last year, the firm earned $2.96 earnings per share. The company’s revenue for the quarter was up .8% on a year-over-year basis.

A number of other brokerages also recently issued reports on CME. Wall Street Zen downgraded CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 12th. Piper Sandler lowered their price target on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a report on Wednesday, July 15th. Morgan Stanley boosted their price target on shares of CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a research report on Thursday, July 23rd. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a research report on Thursday, July 23rd. Finally, Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price on the stock in a report on Thursday, June 18th. Eleven equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $291.81.

CME Group Stock Up 1.8%

Shares of NASDAQ:CME opened at $260.00 on Wednesday. The firm has a market cap of $94.21 billion, a P/E ratio of 22.05, a P/E/G ratio of 2.97 and a beta of 0.25. CME Group has a 12-month low of $218.31 and a 12-month high of $329.16. The business has a fifty day simple moving average of $252.29 and a 200 day simple moving average of $281.12. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were issued a dividend of $1.30 per share. The ex-dividend date was Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 2.0%. CME Group’s dividend payout ratio is currently 44.11%.

Insider Transactions at CME Group

In related news, Director William R. Shepard acquired 325 shares of the business’s stock in a transaction dated Thursday, June 25th. The shares were bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the transaction, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares of the company’s stock, valued at $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.30% of the company’s stock.

Institutional Trading of CME Group

A number of hedge funds and other institutional investors have recently bought and sold shares of CME. Lederer & Associates Investment Counsel CA lifted its stake in shares of CME Group by 13.1% in the second quarter. Lederer & Associates Investment Counsel CA now owns 5,424 shares of the financial services provider’s stock valued at $1,198,000 after buying an additional 627 shares in the last quarter. Handelsbanken Fonder AB increased its position in shares of CME Group by 0.7% during the second quarter. Handelsbanken Fonder AB now owns 129,709 shares of the financial services provider’s stock worth $28,644,000 after acquiring an additional 915 shares in the last quarter. Perkins Coie Trust Co raised its holdings in shares of CME Group by 9.0% in the 2nd quarter. Perkins Coie Trust Co now owns 2,613 shares of the financial services provider’s stock worth $577,000 after acquiring an additional 215 shares during the last quarter. Financial Management Professionals Inc. raised its holdings in shares of CME Group by 24.7% in the 2nd quarter. Financial Management Professionals Inc. now owns 2,053 shares of the financial services provider’s stock worth $453,000 after acquiring an additional 406 shares during the last quarter. Finally, Harrell Investment Partners LLC lifted its position in CME Group by 2.5% in the 2nd quarter. Harrell Investment Partners LLC now owns 26,479 shares of the financial services provider’s stock valued at $5,847,000 after acquiring an additional 653 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.